The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression.
Arto Yuwono SoerotoHendarsyah SuryadinataTheo Audi YantoTimotius Ivan HariyantoPublished in: Inflammopharmacology (2023)
Our study suggests that treatment with thymosin alpha-1 may reduce mortality rate in moderate to critical COVID-19 patients. Randomized clinical trials (RCTs) are still required to verify the findings of our study.